Results 1 - 20 of 176 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (146)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized TrialCirculation (New York, N.Y.), 2014-10, Vol.130 (18), p.1579-1588 [Peer Reviewed Journal]2015 INIST-CNRS ;2014 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.114.010389 ;PMID: 25189213 ;CODEN: CIRCAZFull text available |
| 2 |
Material Type: Article
|
|
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes MellitusThe New England journal of medicine, 2013-10, Vol.369 (14), p.1317-1326 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1307684 ;PMID: 23992601 ;CODEN: NEJMAGFull text available |
| 3 |
Material Type: Article
|
|
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in JapanAnnals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1305-1319 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215164 ;PMID: 31350269Full text available |
| 4 |
Material Type: Article
|
|
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metforminDiabetes care, 2015-03, Vol.38 (3), p.376-383 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Mar 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-1142 ;PMID: 25352655 ;CODEN: DICAD2Full text available |
| 5 |
Material Type: Article
|
|
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid TumorsClinical cancer research, 2017-08, Vol.23 (16), p.4642-4650 [Peer Reviewed Journal]2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Aug 15, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-16-2363 ;PMID: 28420720Full text available |
| 6 |
Material Type: Article
|
|
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1320-1332 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215163 ;PMID: 31350270Full text available |
| 7 |
Material Type: Article
|
|
Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 DiabetesThe journal of clinical endocrinology and metabolism, 2004-05, Vol.89 (5), p.2078-2084 [Peer Reviewed Journal]Copyright © 2004 by The Endocrine Society ;2004 INIST-CNRS ;ISSN: 0021-972X ;ISSN: 1945-7197 ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2003-031907 ;PMID: 15126524 ;CODEN: JCEMAZFull text available |
| 8 |
Material Type: Article
|
|
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 DiabetesDiabetes care, 2017-02, Vol.40 (2), p.284-286 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Feb 1, 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-1707 ;PMID: 27659407 ;CODEN: DICAD2Full text available |
| 9 |
Material Type: Article
|
|
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasisBritish journal of dermatology (1951), 2015-09, Vol.173 (3), p.767-776 [Peer Reviewed Journal]2015 The Authors. published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. ;2015 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. ;Copyright © 2015 British Association of Dermatologists ;ISSN: 0007-0963 ;EISSN: 1365-2133 ;DOI: 10.1111/bjd.13745 ;PMID: 25704750Full text available |
| 10 |
Material Type: Article
|
|
Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 DiabetesDiabetes care, 2015-11, Vol.38 (11), p.2009-2017 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Nov 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-0779 ;PMID: 26246458 ;CODEN: DICAD2Full text available |
| 11 |
Material Type: Article
|
|
Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 StudyJournal of Crohn's and colitis, 2018-11, Vol.12 (10), p.1158-1169 [Peer Reviewed Journal]ISSN: 1873-9946 ;EISSN: 1876-4479 ;DOI: 10.1093/ecco-jcc/jjy085 ;PMID: 29917064Full text available |
| 12 |
Material Type: Article
|
|
Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin AloneDiabetes care, 2009-09, Vol.32 (9), p.1649-1655 [Peer Reviewed Journal]2009 INIST-CNRS ;COPYRIGHT 2009 American Diabetes Association ;Copyright American Diabetes Association Sep 2009 ;2009 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc08-1984 ;PMID: 19478198 ;CODEN: DICAD2Full text available |
| 13 |
Material Type: Article
|
|
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet (British edition), 2006-11, Vol.368 (9548), p.1696-1705 [Peer Reviewed Journal]2006 Elsevier Ltd ;2006 INIST-CNRS ;Copyright Lancet Ltd. Nov 11-Nov 17, 2006 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(06)69705-5 ;PMID: 17098089 ;CODEN: LANCAOFull text available |
| 14 |
Material Type: Article
|
|
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trialDiabetes care, 2015-06, Vol.38 (6), p.1145-1153 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Jun 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-2868 ;PMID: 25758769 ;CODEN: DICAD2Full text available |
| 15 |
Material Type: Article
|
|
Selective inhibition of striatal fast-spiking interneurons causes dyskinesiasThe Journal of neuroscience, 2011-11, Vol.31 (44), p.15727-15731 [Peer Reviewed Journal]Copyright © 2011 the authors 0270-6474/11/3115727-05$15.00/0 2011 ;ISSN: 0270-6474 ;EISSN: 1529-2401 ;DOI: 10.1523/jneurosci.3875-11.2011 ;PMID: 22049415Full text available |
| 16 |
Material Type: Article
|
|
Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 DiabetesDiabetes care, 2015-11, Vol.38 (11), p.2018-2024 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Nov 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-0811 ;PMID: 26324329 ;CODEN: DICAD2Full text available |
| 17 |
Material Type: Article
|
|
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patientsJournal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1558-1566 [Peer Reviewed Journal]The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;Copyright Oxford Publishing Limited(England) May 2015 ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dku553 ;PMID: 25630641Full text available |
| 18 |
Material Type: Article
|
|
Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 TrialDiabetes care, 2015-11, Vol.38 (11), p.2142-2150 [Peer Reviewed Journal]2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Nov 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc15-1068 ;PMID: 26358285 ;CODEN: DICAD2Full text available |
| 19 |
Material Type: Article
|
|
Cardiovascular and heart failure safety profile of vildagliptin: a meta-analysis of 17 000 patientsDiabetes, obesity & metabolism, 2015-11, Vol.17 (11), p.1085-10922015 John Wiley & Sons Ltd ;2015 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12548 ;PMID: 26250051Full text available |
| 20 |
Material Type: Article
|
|
Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated AngioedemaHypertension (Dallas, Tex. 1979), 2009-09, Vol.54 (3), p.516-523 [Peer Reviewed Journal]2009 American Heart Association, Inc. ;2009 INIST-CNRS ;ISSN: 0194-911X ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.109.134197 ;PMID: 19581505 ;CODEN: HPRTDNFull text available |
Results 1 - 20 of 176 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (146)
Refine My Results
Creation Date
- Before 2005 (5)
- 2005 To 2008 (26)
- 2009 To 2012 (45)
- 2013 To 2017 (87)
- After 2017 (14)
-
More options
Subject
- Adamantane - Analogs & Derivatives (175)
- Humans (174)
- Science & Technology (166)
- Life Sciences & Biomedicine (164)
- Diabetes Mellitus, Type 2 - Drug Therapy (125)
- Female (120)
- Male (120)
- Middle Aged (98)
- Dipeptidyl-Peptidase Iv Inhibitors - Adverse Effects (95)
- Hypoglycemic Agents - Adverse Effects (90)
- Pyrrolidines - Adverse Effects (89)
- Nitriles - Adverse Effects (87)
- Adamantane - Therapeutic Use (86)
- Endocrinology & Metabolism (74)
- Aged (72)
- Treatment Outcome (72)
- Adult (67)
- Adamantane - Administration & Dosage (66)
- Diabetes (65)
-
More options
Databases
- MEDLINE (176)
- ProQuest Central (90)
- Geneva Foundation Free Medical Journals at publisher websites (66)
- Open Access: PubMed Central (55)
- DOAJ Directory of Open Access Journals (44)
- ROAD: Directory of Open Access Scholarly Resources (38)
- HighWire Press (Free Journals) (29)
- Taylor & Francis Open Access (17)
- Dove Press Free (15)
- Springer_OA刊 (13)
- Wiley-Blackwell Titles (Open access) (10)
- SWEPUB Freely available online (6)
- Journals@Ovid Open Access Journal Collection Rolling (5)
- ProQuest One Psychology (5)
- BMJ Open Access Journals (3)
- IngentaConnect (3)
- Freely Accessible Japanese Titles (2)
- PLoS (2)
- Sage Journals GOLD Open Access 2024 (2)
- Mary Ann Liebert Online - Open Access (1)
-
More options
Language
- English (172)
- Japanese (22)
- Spanish (2)
- Portuguese (1)
- Russian (1)
- German (1)
-
More options
Journal Title
- Cardiovascular Diabetology (7)
- Clinical Drug Investigation (4)
- Diabetes Care (14)
- Diabetes, Obesity & Metabolism (25)
- Diabetes, Obesity And Metabolism (4)
- Diabetes/metabolism Research And Reviews (4)
- Diabetic Medicine (4)
- Endocrine Practice (4)
- International Journal Of Clinical Practice (6)
- Vascular Health And Risk Management (13)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||